Symbiotec Pharmalab Pvt. Ltd.

About Symbiotec Pharmalab Pvt. Ltd.

Symbiotec develop, manufacture and markets research-based hormone, steroids, nutraceuticals APIs catering to >65 markets. Symbiotec manufacturing facilities are approved by US FDA, EU GMP, PMDA, KFDA, ANVISA, WHO-GMP and ISO 9000:2000. Having served the Global Pharmaceutical Industry for over two decades, we have achieved this distinction with our commitment to quality, efficiency, flexibility, supply and cost competitiveness. 45 DMF and 25 CEPs.

Certifications
  • IN
  • 2015
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Animal Health
API Producer
Biopharmaceutical
Contract Manufacturer
Cosmetic Ingredients
Custom Manufacturing/Custom Synthesis
Intermediates Manufacturer
Nutraceuticals
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Symbiotec Pharmalab Pvt. Ltd. (5)

  • 16-?-hydroxyprednisolone

    Product 16-?-hydroxyprednisolone

    Symbiotec produces an markets a wide range of carticosteroid API's which includes 16-?-hydroxyprednisolone. Contact us for more information.
  • Abiraterone Actetae

    Product Abiraterone Actetae

    Abiraterone Actetae
  • Allylestrenol

    Product Allylestrenol

    Symbiotec produces an markets a wide range of hormone API's which includes allylestrenol. Contact us for more information.
  • Beclometasone Dipropionate

    Product Beclometasone Dipropionate

    Symbiotec produces an markets a wide range of carticosteroid API's which includes beclometasone dipropionate. Contact us for more information.
  • Betamethasone

    Product Betamethasone

    Symbiotec produces an markets a wide range of carticosteroid API's which includes betamethasone. Contact us for more information.

Symbiotec Pharmalab Pvt. Ltd. Resources (1)